Myomo (MYO) Shareholder's Equity (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.06 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.98 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 49.20 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 26.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.96 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.67 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.20 Bn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | 11.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.40 Mn |
| Sep 30, 2025 | 14.63 Mn |
| Jun 30, 2025 | 17.62 Mn |
| Mar 31, 2025 | 21.69 Mn |
| Dec 31, 2024 | 24.71 Mn |
| Sep 30, 2024 | 9.29 Mn |
| Jun 30, 2024 | 9.68 Mn |
| Mar 31, 2024 | 10.90 Mn |
| Dec 31, 2023 | 8.99 Mn |
| Sep 30, 2023 | 11.02 Mn |
| Jun 30, 2023 | 8.82 Mn |
| Mar 31, 2023 | 9.63 Mn |
| Dec 31, 2022 | 6.36 Mn |
| Sep 30, 2022 | 7.82 Mn |
| Jun 30, 2022 | 10.35 Mn |
| Mar 31, 2022 | 12.87 Mn |
| Dec 31, 2021 | 15.41 Mn |
| Sep 30, 2021 | 13.15 Mn |
| Jun 30, 2021 | 13.81 Mn |
| Mar 31, 2021 | 16.07 Mn |
| Dec 31, 2020 | 11.57 Mn |
| Sep 30, 2020 | 12.98 Mn |
| Jun 30, 2020 | 10.05 Mn |
| Mar 31, 2020 | 11.78 Mn |
| Dec 31, 2019 | 6.43 Mn |
| Sep 30, 2019 | 4.42 Mn |
| Jun 30, 2019 | 7.06 Mn |
| Mar 31, 2019 | 9.44 Mn |
| Dec 31, 2018 | 6.43 Mn |
| Sep 30, 2018 | 8.95 Mn |
| Jun 30, 2018 | 11.45 Mn |
| Mar 31, 2018 | 13.92 Mn |
| Dec 31, 2017 | 12.45 Mn |
| Sep 30, 2017 | 2.58 Mn |
| Jun 30, 2017 | 3.92 Mn |
| Dec 31, 2016 | -17.53 Mn |